Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Daniel F B Wright"'
Autor:
Lisa Stamp, Nicola Dalbeth, Chris Frampton, Susan Reid, Leanne Te Karu, Daniel F B Wright, Vui Suli Tuitaupe
Publikováno v:
BMJ Open, Vol 14, Iss 8 (2024)
Introduction Gout is one of the most common forms of arthritis worldwide. Gout is particularly prevalent in Aotearoa/New Zealand and is estimated to affect 13.1% of Māori men, 22.9% of Pacific men and 7.4% of New Zealand European men. Effective long
Externí odkaz:
https://doaj.org/article/3cf06f11e09e4eeca65e641bc5adf541
Autor:
Isabelle H S Kuan, Luke C Wilson, Jed C Leishman, Samuel Cosgrove, Robert J Walker, Tracey L Putt, John B W Schollum, Daniel F B Wright
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246247 (2021)
We aimed to develop a metformin dosing strategy to optimise efficacy and safety in patients with reduced kidney function. Metformin data from two studies stratified by kidney function were analysed. The relationship between metformin clearance and ki
Externí odkaz:
https://doaj.org/article/12d0d9a0239743b5a988c18b03bc46ef
Autor:
Lisa K. Stamp, Peter T. Chapman, Murray Barclay, Anne Horne, Christopher Frampton, Tony R. Merriman, Daniel F. B. Wright, Jill Drake, Nicola Dalbeth
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 1, Pp 110-115 (2020)
The aims of this study were to determine factors that predict serum urate (SU) lowering response to allopurinol and the conversion of allopurinol to oxypurinol, and to determine a minimum therapeutic oxypurinol concentration. Data from 129 participan
Externí odkaz:
https://doaj.org/article/d6847952861c41d2860326047a0c9301
Autor:
Hailemichael Z. Hishe, Sophie L. Stocker, Lisa K. Stamp, Nicola Dalbeth, Tony R. Merriman, Amanda Phipps‐Green, Daniel F. B. Wright
Publikováno v:
Clinical and Translational Science. 16:422-428
The genetic determinants of the allopurinol dose-concentration relationship have not been extensively studied. We aimed to clarify what factors, including genetic variation in urate transporters, influence oxypurinol pharmacokinetics (PKs). A populat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a88b50214efe4667119701db1e8583
https://doi.org/10.1111/cts.13460
https://doi.org/10.1111/cts.13460
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. 12:285-287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec98d238360c396bcabb78162554979a
https://doi.org/10.1002/psp4.12909
https://doi.org/10.1002/psp4.12909
Publikováno v:
British Journal of Clinical Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e884e687a69cc29cd531ab5b1aeac955
https://doi.org/10.1111/bcp.15722
https://doi.org/10.1111/bcp.15722
Publikováno v:
Pharmacy, Vol 8, Iss 2, p 83 (2020)
(1) Background: The processes and skills required to make decisions about drug therapy have been termed “therapeutic decision-making” in pharmacy practice. The aim of this study was to evaluate a tool constructed to measure the development of the
Externí odkaz:
https://doaj.org/article/5c1273d0404f4920889b2cbd19eb835d
Autor:
Natalia Smith‐Diaz, Sophie L. Stocker, Lisa K. Stamp, Nicola Dalbeth, Amanda J. Phipps‐Green, Tony R. Merriman, Daniel F. B. Wright
Publikováno v:
British Journal of Clinical Pharmacology.
This study aimed to develop and evaluate an allopurinol adherence tool based on steady-state oxypurinol plasma concentrations, allopurinol's active metabolite.Plasma oxypurinol concentrations were simulated stochastically from an oxypurinol pharmacok
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05243d6152a4b856018736f38448192b
https://doi.org/10.1111/bcp.15516
https://doi.org/10.1111/bcp.15516
Autor:
Robert R. Bies, Daniel F. B. Wright
Publikováno v:
British Journal of Clinical Pharmacology. 88:1403-1405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f82f7aa6498a5551448e28ba274b5074
https://doi.org/10.1111/bcp.15289
https://doi.org/10.1111/bcp.15289
Autor:
Stephen B. Duffull, Tracey L. Putt, Daniel F. B. Wright, Robert J. Walker, Sudeep Pradhan, John B. W. Schollum, Luke C. Wilson, Isabelle H. S. Kuan
Publikováno v:
British Journal of Clinical Pharmacology. 87:4868-4876
This research explored the intact nephron hypothesis (INH) as a model for metformin dosing in patients with chronic kidney disease (CKD). The INH assumes that glomerular filtration rate (GFR) will account for all kidney drug handling even for drugs e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3bf1925136f788a9c5ce2754b437bcb
https://doi.org/10.1111/bcp.14919
https://doi.org/10.1111/bcp.14919